Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRUS Merus B.V.

盘前交易 11-18 07:18:51 EST

46.58

-3.08

-6.20%

最高50.98	最低46.05	成交量58.78万
今开49.33	昨收49.66	日振幅9.93%
总市值31.89亿	流通市值29.30亿	总股本6,846万
成交额2,777万	换手率0.93%	流通股本6,290万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRUS","market":"US","secType":"STK","nameCN":"Merus B.V.","latestPrice":46.58,"timestamp":1731704400000,"preClose":49.66,"halted":0,"volume":587762,"delay":0,"floatShares":62897549,"shares":68463681,"eps":-3.97531,"marketStatus":"盘前交易","marketStatusCode":1,"change":-3.08,"latestTime":"11-18 07:18:51 EST","open":49.33,"high":50.975,"low":46.045,"amount":27767859.988988,"amplitude":0.099275,"askPrice":47.42,"askSize":47,"bidPrice":18.64,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.97531,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731940200000},"adr":0,"listingDate":1463630400000,"adjPreClose":46.58,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":46.58,"preClose":46.58,"latestTime":"17:42 EST","volume":4837,"amount":225307.46,"timestamp":1731710542903},"volumeRatio":1.8888576105700234,"impliedVol":0.7648,"impliedVolPercentile":0.532},"requestUrl":"/m/hq/s/MRUS","defaultTab":"news","newsList":[{"id":"2483558900","title":"Merus N.V.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483558900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483558900?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:18","pubTimestamp":1731698312,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时18分，Merus N.V.股票出现波动，股价快速跳水5.02%。截至发稿，该股报47.17美元/股，成交量28.275万股，换手率0.41%，振幅7.54%。Merus N.V.股票所在的生物技术行业中，整体跌幅为3.87%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116031833971a6f04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116031833971a6f04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","MRUS"],"gpt_icon":0},{"id":"2480360130","title":"Merus N.V.2024财年第三财季实现净利润-99.91百万美元，同比减少334.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480360130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480360130?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:00","pubTimestamp":1730649620,"startTime":"0","endTime":"0","summary":"11月4日，Merus N.V.公布财报，公告显示公司2024财年第三财季净利润为-99.91百万美元，同比减少334.20%；其中营业收入为11.77百万美元，同比增加6.71%，每股基本收益为-1.46美元。机构评级：截至2024年11月4日，当前有15家机构对Merus N.V.目标价做出预测，其中目标均价为87.73美元，其中最低目标价为67.00美元，最高目标价为111.00美元。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000025ab9b4e23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000025ab9b4e23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS"],"gpt_icon":0},{"id":"2457749732","title":"Needham：维持Merus(MRUS.US)评级，由买入调整至买入评级, 目标价由92.00美元调整至85.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457749732","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457749732?lang=zh_cn&edition=full","pubTime":"2024-08-05 17:30","pubTimestamp":1722850250,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LU0889565916.HKD","MRUS","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2452625481","title":"Merus N.V.盘中异动 急速跳水5.17%报55.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452625481","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452625481?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:28","pubTimestamp":1721233692,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时28分，Merus N.V.股票出现波动，股价快速跳水5.17%。截至发稿，该股报55.80美元/股，成交量35.1294万股，换手率0.52%，振幅5.88%。Merus N.V.股票所在的生物技术行业中，整体跌幅为1.97%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002812aefa2903&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002812aefa2903&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS","LU0889565916.HKD","LU0109394709.USD","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"2449983706","title":"Merus N.V.盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449983706","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449983706?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:04","pubTimestamp":1720447484,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时04分，Merus N.V.股票出现异动，股价急速上涨5.05%。截至发稿，该股报56.04美元/股，成交量5.5886万股，换手率0.08%，振幅4.00%。Merus N.V.股票所在的生物技术行业中，整体涨幅为0.68%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708220445aef879a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708220445aef879a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS","VRPX","LU0889565916.HKD","BK4139","LU0109394709.USD","BK4007","LU0320765992.SGD"],"gpt_icon":0},{"id":"2448913100","title":"Merus N.V.股价重挫13.60% 市值跌4.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913100","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448913100?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:31","pubTimestamp":1719840688,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时31分，Merus N.V.股票出现异动，股价急速下跌13.60%。截至发稿，该股报51.12美元/股，成交量10.1403万股，换手率0.15%，振幅4.02%。Merus N.V.股票所在的生物技术行业中，整体跌幅为0.05%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131299eed3938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407012131299eed3938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139","MRUS"],"gpt_icon":0},{"id":"2446565892","title":"Merus N.V.盘中异动 下午盘急速拉升5.04%报59.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446565892","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446565892?lang=zh_cn&edition=full","pubTime":"2024-06-28 01:14","pubTimestamp":1719508477,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日01时14分，Merus N.V.股票出现异动，股价快速拉升5.04%。截至发稿，该股报59.87美元/股，成交量81.0046万股，换手率1.20%，振幅6.97%。Merus N.V.股票所在的生物技术行业中，整体跌幅为0.43%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628011437aef6f43f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628011437aef6f43f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4139","LU0109394709.USD","MRUS"],"gpt_icon":0},{"id":"2444165748","title":"Stifel：维持Merus(MRUS.US)评级，由买入调整至买入评级, 目标价由90.00美元调整至99.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2444165748","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444165748?lang=zh_cn&edition=full","pubTime":"2024-06-17 19:48","pubTimestamp":1718624913,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","MRUS","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2442106143","title":"Merus N.V.盘中异动 股价大涨5.01%报56.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442106143","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442106143?lang=zh_cn&edition=full","pubTime":"2024-06-12 01:54","pubTimestamp":1718128468,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日01时54分，Merus N.V.股票出现波动，股价快速拉升5.01%。截至发稿，该股报56.00美元/股，成交量80.1698万股，换手率1.19%，振幅5.14%。机构评级方面，在所有15家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Merus N.V.股票所在的生物技术行业中，整体跌幅为0.07%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612015429aef45f5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612015429aef45f5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","MRUS","BK4139"],"gpt_icon":0},{"id":"2440362812","title":"加拿大蒙特利尔银行：维持Merus(MRUS.US)评级，由优于大市调整至优于大市评级, 目标价由84.00美元调整至91.","url":"https://stock-news.laohu8.com/highlight/detail?id=2440362812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440362812?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:03","pubTimestamp":1717509804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMO","LU0889565916.HKD","BK4139","MRUS","LU0320765992.SGD","BK4207","LU0109394709.USD"],"gpt_icon":0},{"id":"2439980549","title":"Merus N.V.：H.C. Wainwright 将目标价从65美元上调至85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439980549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439980549?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:16","pubTimestamp":1716977789,"startTime":"0","endTime":"0","summary":"Merus N.V.：H.C. Wainwright 将目标价从65美元上调至85美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291816319eff1ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291816319eff1ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS"],"gpt_icon":0},{"id":"2439580799","title":"Merus NV：将发行的净收益用于推进其候选产品的临床开发用于临床前研究和技术开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2439580799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439580799?lang=zh_cn&edition=full","pubTime":"2024-05-29 04:17","pubTimestamp":1716927421,"startTime":"0","endTime":"0","summary":"Merus NV：将发行的净收益用于推进其候选产品的临床开发用于临床前研究和技术开发","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052904170295710367&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052904170295710367&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0889565916.HKD","MRUS","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2439030756","title":"BUZZ-Merus 因投资者对癌症疗法组合试验结果的担忧而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2439030756","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439030756?lang=zh_cn&edition=full","pubTime":"2024-05-29 00:26","pubTimestamp":1716913598,"startTime":"0","endTime":"0","summary":"    5月28日 - ** 在美国上市的荷兰Merus NV   股价下跌8.5%至55美元左右 ** 威廉-布莱尔公司的分析师说，Merus公司的组合癌症疗法试验的最新中期数据使该公司有机会获得多大片，但买方正在回调。** 该公司报告称，  其主要候选药物与默克公司  的Keytruda联合治疗一线头颈部癌症患者的早中期试验的最新中期数据。** Merus的最新数据显示，在24名可评估的患者中，肿瘤缩小或消失的反应率为67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU1989772923.USD","SG9999014542.SGD","LU2461242641.AUD","LU1430594728.SGD","LU0289739699.SGD","IE0002141913.USD","LU0965509010.AUD","LU0320765489.SGD","LU0965509283.SGD","LU0208291251.USD","MRK","IE00BSNM7G36.USD","IE00B2B36J28.USD","IE00BLSP4239.USD","MRUS","LU2023250843.SGD","BK4588","IE00B1BXHZ80.USD","LU1989772840.SGD","LU1066051498.USD","LU1057294990.SGD","LU1023059063.AUD","LU1093756325.SGD","SG9999001176.SGD","SG9999002232.USD","LU2468319806.SGD","LU2361044865.SGD","SG9999001176.USD","LU2361045086.USD","SG9999014567.USD","LU1974910355.USD","LU0266013472.USD","LU2106854487.HKD","LU0109394709.USD","LU2361044949.HKD","BK4550","BUZZ","IE00BFTCPJ56.SGD","BK4007","BK4533","SG9999002224.SGD","SG9999014559.SGD","LU2023250504.SGD","LU1917777945.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU1585245621.USD","LU0211331839.USD","LU1291159041.SGD"],"gpt_icon":0},{"id":"2438054503","title":"Stifel：维持Merus(MRUS.US)评级，由买入调整至买入评级, 目标价由65.00美元调整至90.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2438054503","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438054503?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:36","pubTimestamp":1716906976,"startTime":"0","endTime":"0","summary":"Stifel：维持Merus(MRUS.US)评级，由买入调整至买入评级, 目标价由65.00美元调整至90.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282236219ef9eb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282236219ef9eb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRUS"],"gpt_icon":0},{"id":"2438676303","title":"Stifel：维持Merus(MRUS.US)评级，由买入调整至买入评级, 目标价由65.00美元调整至90.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2438676303","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438676303?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:29","pubTimestamp":1716906559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LU0889565916.HKD","MRUS","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2438377443","title":"Merus N.V.盘中异动 早盘股价大跌5.03%报56.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438377443","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438377443?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:36","pubTimestamp":1716903384,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时36分，Merus N.V.股票出现异动，股价快速下挫5.03%。截至发稿，该股报56.97美元/股，成交量41.6132万股，换手率0.71%，振幅3.83%。Merus N.V.股票所在的生物技术行业中，整体跌幅为1.09%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213625af8ab322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213625af8ab322&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4139","LU0889565916.HKD","MRUS","LU0109394709.USD"],"gpt_icon":0},{"id":"2438066536","title":"BUZZ-癌症生物技术公司在行业会议召开前因数据跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2438066536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438066536?lang=zh_cn&edition=full","pubTime":"2024-05-25 01:52","pubTimestamp":1716573125,"startTime":"0","endTime":"0","summary":"** 年初至今，MRUS 股价翻番，LEGN 下跌 30.3%，AGEN 下跌 16%，CRBP 涨幅超过六倍","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU0795875169.SGD","LU0882574055.USD","LU1032466523.USD","BK4139","LU0795875086.SGD","LU0889565916.HKD","LU2347655156.SGD","LU1066053197.SGD","CRBP","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU1267930813.SGD","BK4559","BK4550","SG9999002232.USD","LU1059921491.USD","LU1032955483.USD","LU0109394709.USD","BK4505","LU0889566641.SGD","LU0466842654.USD","LEGN","BK4585","LU0912757837.SGD","BK4592","LU2602419157.SGD","SG9999002224.SGD","LU1221951046.USD","SG9999001440.SGD","AGEN","BK4007","LU1221951129.SGD","LU0234572021.USD","LU1430594728.SGD","LU1244550494.USD","LU1244550221.USD","LU1935042991.SGD","JNJ","MRUS","BK4581","LU1506573853.SGD","LU2133065610.SGD","BK4588","LU0640476718.USD","LU1196500208.SGD","BK4504","BK4568","BUZZ","LU1074936037.SGD"],"gpt_icon":0},{"id":"2438605789","title":"BUZZ--美国股票走势-XPO、Howmet Aerospace、Martin Midstream","url":"https://stock-news.laohu8.com/highlight/detail?id=2438605789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438605789?lang=zh_cn&edition=full","pubTime":"2024-05-25 00:05","pubTimestamp":1716566730,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      5月24日 - 美国股指周五开盘走高，但蓝筹股道指和基准股指标普500指数将结束连续四周的涨势，原因是通胀忧虑在长周末前重燃货币政策谨慎情绪。美东时间11:38，道琼斯工业平均指数  上涨0.22%，报39,150.93点。标普500指数  上涨0.67%，报5,303.39点；纳斯达克综合指数  上涨1.02%，报16,906.867点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOG","SQQQ","QLD","NQmain","IOVA","INTU","QQQ","VSTM","LU0170899867.USD","LCID","CADL","MMLP","TQQQ","LU0149725797.USD","WDAY","BK4515","LU0289739343.SGD","LU0097036916.USD","AAPL","QID","XPO","FOUR","LU0109392836.USD","HWM","FDX","MNQmain","DJX","IE00B775SV38.USD","LU0127658192.USD","IE00BJTD4V19.USD","LU0011850046.USD","LU0109394709.USD",".DJI","DDM","BK4585","LU2265009873.SGD","BUZZ","UDOW","NCTY","IE00BKVL7J92.USD","BKE","DXD","BK4196","BK4022",".SPX","SDOW","PSQ","GH",".IXIC","MRUS"],"gpt_icon":0},{"id":"2437037128","title":"Merus N.V.股价飙升19.06% 市值涨5.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437037128","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437037128?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:31","pubTimestamp":1716557503,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时31分，Merus N.V.股票出现波动，股价大幅上涨19.06%。截至发稿，该股报52.47美元/股，成交量31.7519万股，换手率0.54%，振幅0.48%。Merus N.V.股票所在的生物技术行业中，整体跌幅为0.06%。Merus N.V.公司简介：Merus NV是一家临床阶段的免疫肿瘤学公司。Merus的可报告部分只有双特异性治疗的发现和发展部门。该信息摘要如下：Needham分析师Ami Fadia维持$Merus $买入评级，维持目标价66美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213143955940fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524213143955940fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0109394709.USD","BK4139","LU0320765992.SGD","MRUS"],"gpt_icon":0},{"id":"2437032603","title":"BUZZ-癌症治疗组合疗法中期数据良好，Merus 公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2437032603","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437032603?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:12","pubTimestamp":1716556335,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月24日 - ** 在美国上市的荷兰Merus NV   股价盘前大涨18.5%至52.2美元** 该公司在中期数据 (link) 中称，其实验性疗法 petosemtamab 与默克公司  的 Keytruda 联用后，10 名头颈部癌症患者的肿瘤缩小或消失率达到 60%。** 预计将于 5 月 28 日披露全部数据** 券商 BofA 称初步试验结果表明其疗效令人信服，并将其目标股价从 52 美元上调至 61 美元。** 截至上次收盘，该公司股价上涨了60.25%，而纳斯达克生物技术指数  的涨幅仅为1.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","BUZZ","LU0208291251.USD","LU1066053197.SGD","IE00BSNM7G36.USD","LU0965509101.SGD","LU1430594728.SGD","LU0965509010.AUD","MRK","IE00B1BXHZ80.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU1093756168.USD","BK4139","LU1974910355.USD","LU0238689110.USD","SG9999014542.SGD","IE0009355771.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2106854487.HKD","IE00BLSP4452.SGD","MRUS","SG9999014559.SGD","LU0985320562.USD","SG9999013999.USD","LU0965509283.SGD","BK4588","LU0889565916.HKD","SG9999001176.USD","SG9999002232.USD","LU2023250504.SGD","LU0070302665.USD","LU0109394709.USD","BK4534","BK4585","LU1057294990.SGD","SG9999001440.SGD","LU1585245621.USD","LU2023250843.SGD","LU2468319806.SGD","SG9999014567.USD","LU1023059063.AUD","LU1291159041.SGD","LU0861579265.USD","LU1917777945.USD","LU0266013472.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merus.nl","stockEarnings":[{"period":"1week","weight":-0.1453},{"period":"1month","weight":-0.1094},{"period":"3month","weight":-0.0983},{"period":"6month","weight":0.0608},{"period":"1year","weight":0.9571},{"period":"ytd","weight":0.6938}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Merus N.V.是在荷兰法律下成立于2003年6月16日。该公司是一个临床阶段的免疫肿瘤学公司开发创新的双特异性抗体治疗。其全长人双特异性抗体的候选人的管道，他们将其称为biclonics，从他们技术平台产生。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.108806},{"month":2,"riseRate":0.5,"avgChangeRate":0.052429},{"month":3,"riseRate":0.25,"avgChangeRate":-0.025338},{"month":4,"riseRate":0.5,"avgChangeRate":-0.004181},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003831},{"month":6,"riseRate":0.666667,"avgChangeRate":0.081799},{"month":7,"riseRate":0.444444,"avgChangeRate":0.004133},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.009107},{"month":9,"riseRate":0.444444,"avgChangeRate":0.106522},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.037474},{"month":11,"riseRate":0.444444,"avgChangeRate":0.009989},{"month":12,"riseRate":0.875,"avgChangeRate":0.105332}],"exchange":"NASDAQ","name":"Merus B.V.","nameEN":"Merus NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Merus B.V.(MRUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Merus B.V.,MRUS,Merus B.V.股票,Merus B.V.股票老虎,Merus B.V.股票老虎国际,Merus B.V.行情,Merus B.V.股票行情,Merus B.V.股价,Merus B.V.股市,Merus B.V.股票价格,Merus B.V.股票交易,Merus B.V.股票购买,Merus B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Merus B.V.(MRUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Merus B.V.(MRUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}